欢迎来到CSNpharm!产品仅用于科研!

400-920-2911 sales@csnpharm.cn

0

您的位置 : 首页  /  Protein Tyrosine Kinase/RTK  /  IGF-1R  /  XL228

CAS No.: 898280-07-4

XL228 Catalog No. CSN18544

XL228 is a protein kinase inhibitor targeting IGF1R, the Aurora kinases, FGFR1-3, ABL and SRC family kinases.

规格 价格 促销价格 库存 数量
纯度 & 质量文件 批次:

靶点选择性

生物活性

  • 描述
  • 临床研究
  • NCT号适应症或疾病临床期招募状态预计完成时间地点
    NCT00464113Chronic Myeloid Leukemia ... more >> Leukemia, Lymphoblastic, Acute, Philadelphia-Positive Collapse <<Phase 1Terminated(Sponsor decision)-United States, California ... more >> UCLA School of Medicine Los Angeles, California, United States, 90095-1678 University of California San Francisco San Francisco, California, United States, 94143-1270 United States, District of Columbia Georgetown University Medical Center, Lombardi Comprehensive Cancer Center Washington, District of Columbia, United States, 20007 United States, Florida H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 United States, Michigan University of Michigan Health System Ann Arbor, Michigan, United States, 48109 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
    NCT00526838Cancer Lympho... more >>ma Collapse <<Phase 1Terminated(Sponsor decision)-United States, California ... more >> UCLA Jonsson Comprehensive Cancer Center Los Angeles, California, United States, 90095 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Michigan University of Michigan Health System Ann Arbor, Michigan, United States, 48109 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 Collapse <<

实验方案

技术信息

CAS号 898280-07-4 储存条件
分子式 C22H31N9O 运输 蓝冰
分子量 437.54 别名

大规格询价

号为必填项

姓名: 邮箱: 手机号:
留言:
   提交
联系
我们